Highest-materiality recent filing
LifeVantage Q3 revenue drops 25%; EPS falls to $0.11; guidance lowered
Revenue $43.7M, down 25.2% YoY; Americas down 28.9%, Asia/Pacific & Europe down 7.7%.
LifeVantage names Terrence Moorehead CEO; current CEO Steve Fife retiring Apr 30
Steve Fife retires as President and CEO effective April 30, 2026; transition agreement with advisory through Sept 11, 2026.
LifeVantage Q2 revenue drops 27.8% to $48.9M; CEO Fife to retire in April
Revenue $48.9M, down 27.8% YoY; Americas revenue fell 32.6%.
LifeVantage CMO and CIO resign, effective Dec 12 and Dec 24, 2025
CMO Julie Boyster resigns effective December 12, 2025 to pursue other opportunities.
LifeVantage FY2026 annual meeting results: all proposals approved
All seven director nominees elected; Beindorff, Greer, Lewis received >1.9M against votes and 1.87M broker non-votes.
LifeVantage Q1 FY2026 revenue $47.6M (+0.7%), EPS $0.17 vs $0.14 a year ago
Net income $2.2M ($0.17 diluted EPS); adjusted EPS $0.18 vs $0.15.
LifeVantage Q4 revenue $55.1M (+12.6% YoY); full-year EPS $0.75 vs $0.23
Q4 revenue $55.1M (+12.6%); net income $0.15 diluted EPS (adjusted $0.17).
LifeVantage Q3 revenue $58.4M (+21% YoY); EPS $0.26 vs $0.13
Net income $3.5M ($0.26 diluted EPS) vs $1.7M ($0.13) a year ago; adjusted EPS also $0.26 vs $0.21.
LifeVantage Q2 revenue up 31% to $67.8M; raises FY2025 guidance
Revenue $67.8M (+31.3% YoY); Americas +46.3%, APAC/Europe -15.5%.
LifeVantage eliminates Series A Preferred Stock after Rights Agreement expired
Rights Agreement expired Aug 28, 2024; stock purchase rights terminated.
LifeVantage annual meeting results: all eight directors elected, say-on-pay approved
All 8 director nominees elected; votes ranged from 5.59M to 6.19M for.
LifeVantage Q1 revenue falls 8.1% to $47.2M; net income rises to $0.14 diluted EPS
Net income of $0.14 diluted EPS vs $0.05 a year ago; adjusted EPS $0.15 vs $0.13.
LifeVantage Q4 rev down 9.8% to $48.9M; FY adj EPS $0.59; FY25 guidance $200-210M
Q4 GAAP EPS $0.10; adjusted EPS $0.14; revenue down 9.8% YoY to $48.9M.
Erin Brockovich resigns from LifeVantage board; Rajendran Anbalagan appointed
Erin Brockovich resigned from LifeVantage board effective Aug 26, 2024; not due to any disagreement.
LifeVantage Q3 revenue falls 10.2% to $48.2M; guidance cut; adjusted EBITDA up 55%
Revenue $48.2M, down 10.2% YoY; Americas -5.9%, Asia/Pacific & Europe -22.4% (constant currency -16.1%).
LifeVantage enters $5M revolving credit facility with Bank of America, matures 2027
Revolving line of credit up to $5,000,000 with Bank of America; interest at Term SOFR + 2.00% (floor 0.00%).
LifeVantage appoints Dayton Judd to board under cooperation agreement with activist investors
Appointed Dayton Judd to Board; Board size increased by one seat.
On August 23, 2024, Erin Brockovich, a member of the Board of Directors (the “Board”) of LifeVantage Corporation (the “Company”), notified the Company of her resignation as a member of the Board and any committees of the Board, effective August 26, 2024.
On August 26, 2024, the Board, based on the recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Rajendran Anbalagan as a member of the Board, effective immediately.
Effective as of February 14, 2024, Mr. Judd has been appointed as a member of the Board.
Max materiality 0.80 · Median 0.65 · Most common event earnings